Understanding the Immune Response to Personalized Cancer Vaccines: Insights from Intismeran Autogene

• Examining how personalized cancer vaccines generate broad and durable tumor specific immune responses, drawing on findings from the intismeran clinical program
• Discussing how emerging translational insights are deepening our understanding of personalized cancer vaccine biology and informing the future development of this therapeutic approach

Speakers:

Tamara Ouspenskaia

Associate Director, Therapeutics Immunology & Protein Engineering

Moderna Therapeutics